. Effects of 1 mM (n = 2) and 10 µM (n = 9) GS on UDP-sugar levels. Black bar, UDP-Glc; white bar, UDP-GlcA; grey bar, UDP-Hex.
After 2-day-culture period of chondrocytes, an addition of 1 mM concentration of GS for 30 min increased the content of UDP-Hex, while the content of UDP-GlcA and UDP-Glc decreased ( Fig. 2A) . However, addition of 10 µM concentration of GS did not have effect on UDPsugar levels ( Fig. 2A) . After 8-day-culture period, the ratio of UDP-Hex /UDP-Glc, and especially UDP-GlcA/UDP-Glc were higher than in 2-day-cultures (Fig. 2B) . The content of UDP-Hex increased during 30-min-long treatment in 1 mM concentration of GS (Fig. 2B ). Similar to 2-day-culture period, 10 µM concentration of GS did not have any marked effect on the UDP-sugar levels of chondrocytes (Fig. 2B) . Fig. 2 . Effects of different concentration of GS on UDP-sugar levels (n=6). GS-treatment (30 min) was performed two (A) or eight days (B) after chondrocyte isolation and seeding on 6-well-plates. Black bar, UDP-Glc; white bar, UDP-GlcA; grey bar, UDP-Hex. *, p < 0.05.
Effects of GS on aggrecan mRNA expression and GAG synthesis. Table 1 . Aggrecan mRNA expression (n=6) and GAG synthesis (n=12) remained at control level after the cells were treated with 10, 100 µM and 1 mM of GS for 24 hrs (Mean ± S.D.).
Treatment
Relative quantity of aggrecan mRNA expression
Relative 35 S-sulfate incorporation rate Control 1.00 ± 0.11 1.00 ± 0.0 10 µM 1.14 ± 0.11 1.16 ± 0.04 100 µM 1.23 ± 0.16 not determined 1 mM 1.34 ± 0.16 1.15 ± 0.05 DISCUSSION. D-GlcN is naturally made from glucosamine-6-phosphate through fructose-6-phosphate by the enzyme glutamine: fructose-6-phosphate amidotransferase, for use as a precursor for chondroitin sulfate (CS) via formation of UDP-GlcA and UDP-GalNAc. The mechanism of GlcN on OA was initially suggested to be stimulation of cartilage GAG synthesis. It has been shown that serum GlcN concentration reached 1.9-11.5 µM after ingestion of 1500 mg of GS (6). Therefore, we investigated whether exogenous, physiologically available level of GlcN and GS could potentiate CS synthesis in chondrocytes by increasing the intracellular UDP-GlcA and UDP-Hex levels.
No changes in the intracellular UDP-Hex levels were detected after the cells were treated with 10 µM concentration of GS in low-glucose DMEM for 30 or 60 min. Even though the levels of UDP-Hex increased in 1 mM of GS treatment, the level of UDP-GlcA appeared to decrease. Furthermore, 1 mM concentration of GS is much too high to be reached in the extracellular and intracellular fluids after commonly prescribed oral dose. Our finding that low GS concentration does not stimulate CS via increase in UDP-Hex and UDP-GlcA is in line with previous studies with mouse and human chondrocytes (8,9). It has been estimated that the chondrocytes have enough capability to form sufficient level of GlcN for CS synthesis from endogenous glucose (8-10). It was determined that only 9% of galactosamine (GalN) derived from exogenous GlcN was involved in the synthesis of CS in human chondrocytes, while the rest of GalN used in CS synthesis was formed from endogenous glucose (9).
Interestingly, the intracellular levels of UDP-Hex and UDP-GlcA were higher after 8-day-culture period than after 2-day-culture time, and it seems likely that the level of UDP-GlcA could be the rate-limiting factor of GAG synthesis in newly isolated chondrocytes. Low GS concentration did not affect the UDP-sugar levels in 8-day-old cultures.
GS did not significantly affect aggrecan mRNA expression and GAG synthesis, which further confirmed our previous findings (7). Our results indicates that exogenous, physiologically relevant level of GS does not affect the intracellular UDP-hexosamine levels in bovine primary chondrocytes. 
